KEATING LAURIE bought KLRS
August 1, 2026 · Form 4 insider transaction
KEATING LAURIE bought 18,000 shares of Kalaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,000
Price
$0.00
Total value
N/A
InsiderKEATING LAURIE
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 1, 2026
Filing dateAugust 3, 2026
Shares owned after18,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on August 1, 2026. The shares underlying the option are scheduled to vest over three years in equal monthly installments from August 1, 2026 through August 1, 2029, subject to continuous service.